Powder characterization specialist Freeman Technology has reached an agreement with distribution partner DKSH to expand into China. DKSH already distributes Freeman's FT4 Powder Rheometer in Singapore, Malaysia, Thailand and Taiwan and will now distribute the universal powder tester from DKSH China headquarters in Shanghai and other locations in China. Freeman … [Read more...] about Freeman Technology expands Asian business
Business
Fresenius Kabi makes acetylcysteine inhalation solution available
Fresenius Kabi has announced the availability of 30 ml vials acetylcysteine inhalation solution, 20%, helping to alleviate a shortage of the product in the US. The company is marketing the inhalation solution in the US under a licensing agreement with Innopharma, whose ANDA was approved by the FDA in September 2012. The company's President and CEO John Ducker … [Read more...] about Fresenius Kabi makes acetylcysteine inhalation solution available
Aegis gets patent for triptan nasal sprays
The US Patent and Trade Office has awarded Aegis Therapeutics US Patent No. 8,268,791 for "Alkylglycoside compositions for drug administration." The company is highlighting the patent's coverage of fast-acting intranasal triptan formulations for the treatment of migraine headaches that use Aegis's Intravail transmucosal absorption enhancers. Aegis says that this is … [Read more...] about Aegis gets patent for triptan nasal sprays
Melbourn Scientific adds dedicated GMP nasal spray laboratory
In order to meet rising demand for its GMP nasal spray testing services, Melbourn Scientific has dedicated a laboratory to analysis of droplet size, particle characterization, spray pattern, plume geometry, and device performance testing. The company has also appointed Liz Parkhouse as business development executive for the nasal spray testing service. According … [Read more...] about Melbourn Scientific adds dedicated GMP nasal spray laboratory
Proveris expands UK operations, promotes Ivan Prince
OINDP testing specialist Proveris Scientific UK Limited, a wholly owned subsidiary of Proveris Scientific Corporation, is expanding its operations to support increasing business in Asia and Europe. In addition to hiring a new field service engineer specifically for those regions, the company plans to have a new training center at the Chichester headquarters completed … [Read more...] about Proveris expands UK operations, promotes Ivan Prince
Combivent Respimat soft mist inhaler now available in US
Boehringer Ingelheim has launched the Combivent Respimat ipratropium bromide/albuterol soft mist inhaler for the treatment of COPD in the United States. The Combivent Respimat includes enough doses for 30 days, compared to the Combivent MDI, which provides only enough medication for 25 days of treatment. The Combivent MDI, which uses a CFC propellant, will be … [Read more...] about Combivent Respimat soft mist inhaler now available in US
Pulmatrix gets funding from Cystic Fibrosis Foundation Therapeutics for development of PUR118
Cystic Fibrosis Foundation Therapeutics (CFFT) will provide up to $1.4 million to Pulmatrix to support Phase 1b trials of Pulmatrix's lead candidate, PUR118, for the treatment of CF. The collaboration between the nonprofit affiliate of the Cystic Fibrosis Foundation and Pulmatrix also includes "introductions to world-class cystic fibrosis academic researchers and … [Read more...] about Pulmatrix gets funding from Cystic Fibrosis Foundation Therapeutics for development of PUR118
Perrigo files ANDA for albuterol MDI, Teva sues for patent infringement
Teva has filed a lawsuit in the US District Court for the District of Delaware against Perrigo and Catalent after Perrigo filed an ANDA for a generic version of Teva's ProAir HFA albuterol sulfate MDI. The suit alleges infringement of US patents 7,566,445 (Medicinal aerosols and methods of delivery thereof) and 7,105,152 (Suspension aerosol formulations). The '445 … [Read more...] about Perrigo files ANDA for albuterol MDI, Teva sues for patent infringement
FDA approves Apotex azelastine nasal spray
The FDA has approved a generic equivalent to Meda's Astepro, an azelastine nasal spray, 0.1876MG, manufactured by Apotex. Meda filed a patent infringement suit in January 2012 after Apotex submitted its ANDA. The two companies settled after a similar suit regarding Apotex's generic version of Astelin in 2008. View the FDA approval history. … [Read more...] about FDA approves Apotex azelastine nasal spray
Aradigm gets new method of treatment patent for nicotine inhaler
The United States Patent and Trademark Office has issued a method of treatment patent to Aradigm for its inhaled nicotine formulations. US Patent No. 8,256,433, for Systems and Methods for Effecting Cessation of Tobacco Use, provide exclusivity for the systems until January 7, 2024. Aradigm President and CEO Igor Gonda commented, “Tobacco smoking remains an … [Read more...] about Aradigm gets new method of treatment patent for nicotine inhaler